113 related articles for article (PubMed ID: 20142239)
1. Low proportion of false-negative smears in the Finnish program for cervical cancer screening.
Lönnberg S; Anttila A; Kotaniemi-Talonen L; Kujari H; Melkko J; Granroth G; Vornanen M; Pietiläinen T; Sankila A; Arola J; Luostarinen T; Nieminen P
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):381-7. PubMed ID: 20142239
[TBL] [Abstract][Full Text] [Related]
2. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
3. A more accurate measure of the false-negative rate of Papanicolaou smear screening is obtained by determining the false-negative rate of the rescreening process.
Renshaw AA; DiNisco SA; Minter LJ; Cibas ES
Cancer; 1997 Oct; 81(5):272-6. PubMed ID: 9349513
[TBL] [Abstract][Full Text] [Related]
4. Predicting absolute risk of CIN3 during post-colposcopic follow-up: results from the ASCUS-LSIL Triage Study (ALTS).
Walker JL; Wang SS; Schiffman M; Solomon D;
Am J Obstet Gynecol; 2006 Aug; 195(2):341-8. PubMed ID: 16890545
[TBL] [Abstract][Full Text] [Related]
5. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix.
Pairwuti S
Acta Cytol; 1991; 35(1):40-6. PubMed ID: 1994633
[TBL] [Abstract][Full Text] [Related]
6. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
7. High-grade squamous intraepithelial lesions and invasive carcinoma following the report of three negative Papanicolaou smears: screening failures or rapid progression?
Sherman ME; Kelly D
Mod Pathol; 1992 May; 5(3):337-42. PubMed ID: 1495939
[TBL] [Abstract][Full Text] [Related]
8. Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears.
Arbyn M; Schenck U; Ellison E; Hanselaar A
Cancer; 2003 Feb; 99(1):9-16. PubMed ID: 12589640
[TBL] [Abstract][Full Text] [Related]
9. ThinPrep Papanicolaou testing to reduce false-negative cervical cytology.
Linder J; Zahniser D
Arch Pathol Lab Med; 1998 Feb; 122(2):139-44. PubMed ID: 9499356
[TBL] [Abstract][Full Text] [Related]
10. Combined cytology and colposcopy to screen for cervical cancer in pregnancy.
Guerra B; De Simone P; Gabrielli S; Falco P; Montanari G; Bovicelli L
J Reprod Med; 1998 Aug; 43(8):647-53. PubMed ID: 9749413
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer screening. Past success and future challenge.
Dewar MA; Hall K; Perchalski J
Prim Care; 1992 Sep; 19(3):589-606. PubMed ID: 1410065
[TBL] [Abstract][Full Text] [Related]
12. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany.
Bollmann R; Bankfalvi A; Griefingholt H; Trosic A; Speich N; Schmitt C; Bollmann M
Oncol Rep; 2005 May; 13(5):915-22. PubMed ID: 15809758
[TBL] [Abstract][Full Text] [Related]
13. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
[TBL] [Abstract][Full Text] [Related]
14. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
15. The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia.
Ullal A; Roberts M; Bulmer JN; Mathers ME; Wadehra V
Cytopathology; 2009 Dec; 20(6):359-66. PubMed ID: 18557985
[TBL] [Abstract][Full Text] [Related]
16. Results of AutoPap system-assisted and manual cytologic screening. A comparison.
Wertlake P
J Reprod Med; 1999 Jan; 44(1):11-7. PubMed ID: 9987733
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
18. A study of Pap test history and histologically determined cervical cancer in NSW women, 1997-2003.
Morrell S; Taylor R; Wain G
J Med Screen; 2005; 12(4):190-6. PubMed ID: 16417696
[TBL] [Abstract][Full Text] [Related]
19. Improvement in the routine screening of cervical smears: A study using rapid prescreening and 100% rapid review as internal quality control methods.
Tavares SB; Alves de Sousa NL; Manrique EJ; Pinheiro de Albuquerque ZB; Zeferino LC; Amaral RG
Cancer Cytopathol; 2011 Dec; 119(6):367-76. PubMed ID: 21954191
[TBL] [Abstract][Full Text] [Related]
20. Significant reduction in the rate of false-negative cervical smears with neural network-based technology (PAPNET Testing System).
Koss LG; Sherman ME; Cohen MB; Anes AR; Darragh TM; Lemos LB; McClellan BJ; Rosenthal DL; Keyhani-Rofagha S; Schreiber K; Valente PT
Hum Pathol; 1997 Oct; 28(10):1196-203. PubMed ID: 9343327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
